#croi2026 oral abstract session #idsky #hivsky #pitavastatin has benefit beyong lipid lowering: reduces incident HTN (2 fold higher major adverse cardiac risk/ #MACE) in #PLWH

Cholesterol-lowering drug can overcome chemotherapy resistance in triple-negative breast cancer – BioNews Central Pitavastatin, a common cholesterol-lowering drug, counteracts chemotherapy resistance in triple-negative breast cancer cells by directly blocking the anti-apoptotic protein Mcl-1. ...

#Pitavastatin, a common #CholesterolLoweringDrug, counteracts #ChemotherapyResistance in #TripleNegativeBreastCancer cells by directly blocking the anti-apoptotic protein Mcl-1.
#Statins #BreastCancer #BreastCancerTreatment

Korea University Team Finds Cholesterol Drug Can Fight Breast Cancer Resistance Researchers at Korea University have discovered that pitavastatin, a cholesterol-lowering drug, can inhibit a key protein in triple-negative breast cancer, showing promise in overcoming chemotherapy resistance.

Korea University Team Finds Cholesterol Drug Can Fight Breast Cancer Resistance #South_Korea #Seoul #Korea_University #Breast_Cancer #pitavastatin